ETH Zurich researchers use AI to develop drug molecules based on protein structures
The new process makes generating active pharmaceutical ingredients quicker and easier
Read More
Tag: roche
Roche partners with Cardiff researchers to uncover new research into dementia
Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions
Read More
NICE recommends Roche’s Columvi for advanced lymphoma in UK
Around 700 people in the UK could benefit from the new treatment
Read More
PhoreMost in drug target discovery collaboration with Roche
PhoreMost will use Siteseeker platform to identify novel targets for Roche’s discovery programmes
Read More
Roche launches digital PCR system for ultra-rare and emerging diseases
Using the system, the researchers are able to divide DNA and RNA from an already extracted clinical sample into as many as 100,000 microscopic individual reactions
Read More
Roche testing to help diagnose pre-eclampsia receives NICE recommendation
Predicting which women are likely to develop pre-eclampsia will help clinicians to decide on the most appropriate care
Read More
Nordic Bioscience and Roche strengthen collaboration
The companies will focus on the development of biomarkers for chronic diseases
Read More
Thousands to potentially benefit from Roche treatment for sight loss
Faricimab is administered as an eye injection with an interval of up to 16 weeks
Read More
Roche launches molecular system to increase diagnostic testing access
Fully-automated molecular system with small footprint provides greater flexibility for laboratories without much space
Read More
CHMP recommend approval for Roche’s COVID-19 therapy
According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients.
Read More
Roche launches Foundation Medicine-partnered genomic profiling kit
Product designed to allow laboratories to expand in-house oncology research
Read More
NHS patients gain access to COVID-19 treatment Ronapreve
Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19
Read More
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
- Oregon and Lantern collaborate to develop drug candidate for various cancer indications
- OneChain’s CAR T trial treats its first cortical T-cell ALL patient
- Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
